New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells
Roberto Würth(Heidelberg Institute for Stem Cell Technology and Experimental Medicine), Tullio Florio(Ospedale Policlinico San Martino)
Cited by 64
Related Papers
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
|Nature Cancer|2022|224
Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity.
|Journal of Biological Chemistry|1992|92